Journal of the Formosan Medical Association
Volume 108, Issue 10 , Pages 754-764 , October 2009

Risk Factors for Dementia

  • Jen-Hau Chen

      Affiliations

    • Department of Geriatrics and Gerontology, National Taiwan University Hospital, Taipei, Taiwan
    • Institute of Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan
    • Jen-Hau Chen and Kun-Pei Lin contributed equally to this work.
    • ,
  • Kun-Pei Lin

      Affiliations

    • Department of Geriatrics and Gerontology, National Taiwan University Hospital, Taipei, Taiwan
    • Institute of Epidemiology, College of Public Health, National Taiwan University, Taipei, Taiwan
    • Jen-Hau Chen and Kun-Pei Lin contributed equally to this work.
    • ,
  • Yen-Ching Chen

      Affiliations

    • Institute of Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan
    • Research Center for Genes, Environment, and Human Health, College of Public Health, National Taiwan University, Taipei, Taiwan
    • Corresponding Author InformationCorrespondence to: Dr Yen-Ching Chen, Institute of Preventive Medicine, College of Public Health, National Taiwan University, 17 Xu-Zhou Road, Taipei 100, Taiwan

Received 17 September 2008 ,Revised 20 February 2009 ,Accepted 8 April 2009.

References 

  1. Hoyert DL , Kung HC , Smith BL . Deaths: preliminary data for 2003 . Natl Vital Stat Rep . 2005;53:1–48
  2. The World Factbook . Washington, DC: Central Intelligence Agency; 2007;
  3. Albert MS . Changing the trajectory of cognitive decline? . N Engl J Med . 2007;357:502–503
  4. Walsh DM , Selkoe DJ . Deciphering the molecular basis of memory failure in Alzheimer's disease . Neuron . 2004;44:181–193
  5. Liu CK , Tai CT , Lin RT , et al.   Epidemiology of dementia in Taiwan . Appl Psychol Res . 2000;7:157–169
  6. In: Basics of Alzheimer's Disease: What It Is and What You Can Do . Chicago, IL: Alzheimer's Association; 2005;p. 8–9
  7. Selkoe DJ . Defining molecular targets to prevent Alzheimer disease . Arch Neurol . 2005;62:192–195
  8. Heneka MT , O'Banion MK . Inflammatory processes in Alzheimer's disease . J Neuroimmunol . 2007;184:69–91
  9. Wong PC , Cai H , Borchelt DR , et al.   Genetically engineered mouse models of neurodegenerative diseases . Nat Neurosci . 2002;5:633–639
  10. Walsh DM , Klyubin I , Fadeeva JV , et al.   Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo . Nature . 2002;416:535–539
  11. Cagnin A , Brooks DJ , Kennedy AM , et al.   In-vivo measurement of activated microglia in dementia . Lancet . 2001;358:461–467
  12. Heneka MT , Sastre M , Dumitrescu-Ozimek L , et al.   Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice . J Neuroinflammation . 2005;2:22
  13. Moechars D , Dewachter I , Lorent K , et al.   Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain . J Biol Chem . 1999;274:6483–6492
  14. Hu J , Akama KT , Krafft GA , et al.   Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release . Brain Res . 1998;785:195–206
  15. Lindberg C , Selenica ML , Westlind-Danielsson A , et al.   Beta-amyloid protein structure determines the nature of cytokine release from rat microglia . J Mol Neurosci . 2005;27:1–12
  16. White JA , Manelli AM , Holmberg KH , et al.   Differential effects of oligomeric and fibrillar amyloid-beta 1-42 on astrocyte-mediated inflammation . Neurobiol Dis . 2005;18:459–465
  17. Corder EH , Saunders AM , Strittmatter WJ , et al.   Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families . Science . 1993;261:921–923
  18. Gatz M , Fratiglioni L , Johansson B , et al.   Complete ascertainment of dementia in the Swedish Twin Registry: the HARMONY study . Neurobiol Aging . 2005;26:439–447
  19. Pedersen NL , Gatz M , Berg S , et al.   How heritable is Alzheimer's disease late in life? Findings from Swedish twins . Ann Neurol . 2004;55:180–185
  20. Richard F , Amouyel P . Genetic susceptibility factors for Alzheimer's disease . Eur J Pharmacol . 2001;412:1–12
  21. Farrer LA , Cupples LA , Haines JL , et al.   Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium . JAMA . 1997;278:1349–1356
  22. Strittmatter WJ , Saunders AM , Schmechel D , et al.   Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease . Proc Natl Acad Sci USA . 1993;90:1977–1981
  23. Pastor P , Goate AM . Molecular genetics of Alzheimer's disease . Curr Psychiatry Rep . 2004;6:125–133
  24. Du Y , Dodel RC , Eastwood BJ , et al.   Association of an interleukin 1 alpha polymorphism with Alzheimer's disease . Neurology . 2000;55:480–483
  25. Hedley R , Hallmayer J , Groth DM , et al.   Association of interleukin-1 polymorphisms with Alzheimer's disease in Australia . Ann Neurol . 2002;51:795–797
  26. Griffin WS , Mrak RE . Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease . J Leukoc Biol . 2002;72:233–238
  27. Nicoll JA , Mrak RE , Graham DI , et al.   Association of interleukin-1 gene polymorphisms with Alzheimer's disease . Ann Neurol . 2000;47:365–368
  28. McCusker SM , Curran MD , Dynan KB , et al.   Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case–control study . Lancet . 2001;357:436–439
  29. McGeer PL , McGeer EG . Polymorphisms in inflammatory genes and the risk of Alzheimer disease . Arch Neurol . 2001;58:1790–1792
  30. Abraham R , Moskvina V , Sims R , et al.   A genome-wide association study for late-onset Alzheimer's disease using DNA pooling . BMC Med Genomics . 2008;1:44
  31. Bertram L , Lange C , Mullin K , et al.   Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE . Am J Hum Genet . 2008;83:623–632
  32. Carrasquillo MM , Zou F , Pankratz VS , et al.   Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease . Nat Genet . 2009;41:192–198
  33. Kukull WA , Higdon R , Bowen JD , et al.   Dementia and Alzheimer disease incidence: a prospective cohort study . Arch Neurol . 2002;59:1737–1746
  34. Launer LJ , Andersen K , Dewey ME , et al.   Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia . Neurology . 1999;52:78–84
  35. Ganguli M , Dodge HH , Chen P , et al.   Ten-year incidence of dementia in a rural elderly US community population: the MoVIES Project . Neurology . 2000;54:1109–1116
  36. Rocca WA , Cha RH , Waring SC , et al.   Incidence of dementia and Alzheimer's disease: a reanalysis of data from Rochester, Minnesota, 1975–1984 . Am J Epidemiol . 1998;148:51–62
  37. Bachman DL , Wolf PA , Linn RT , et al.   Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study . Neurology . 1993;43:515–519
  38. Kawas C , Gray S , Brookmeyer R , et al.   Age-specific incidence rates of Alzheimer's disease: the Baltimore Longitudinal Study of Aging . Neurology . 2000;54:2072–2077
  39. Lopez-Pousa S , Vilalta-Franch J , Llinas-Regla J , et al.   Incidence of dementia in a rural community in Spain: the Girona cohort study . Neuroepidemiology . 2004;23:170–177
  40. Liu L , Guo XE , Zhou YQ , et al.   Prevalence of dementia in China . Dement Geriatr Cogn Disord . 2003;15:226–230
  41. Urakami K , Adachi Y , Takahashi K . A community-based study of parental age at the birth of patients with dementia of the Alzheimer type . Arch Neurol . 1989;46:38–39
  42. Corkin S , Growdon JH , Rasmussen SL . Parental age as a risk factor in Alzheimer's disease . Ann Neurol . 1983;13:674–676
  43. Bertram L , Busch R , Spiegl M , et al.   Paternal age is a risk factor for Alzheimer disease in the absence of a major gene . Neurogenetics . 1998;1:277–280
  44. Corkin S , Growdon JH , Rasmussen SL . Parental age as a risk factor in Alzheimer's disease . Ann Neurol . 1983;13:674–676
  45. Jouan-Flahault C , Seroussi MC , Colvez A . Absence of a relationship between senile dementia and parental age. A case report survey in Upper Normandy . Rev Epidemiol Sante Publique . 1989;37:73–75 [In French]
  46. Ptok U , Papassotiropoulos A , Maier W , et al.   Advanced parental age: a risk factor for Alzheimer's disease or depression in the elderly? . Int Psychogeriatr . 2000;12:445–451
  47. Andersen K , Launer LJ , Dewey ME , et al.   Gender differences in the incidence of AD and vascular dementia: the EURODEM Studies. EURODEM Incidence Research Group . Neurology . 1999;53:1992–1997
  48. Ruitenberg A , Ott A , van Swieten JC , et al.   Incidence of dementia: does gender make a difference? . Neurobiol Aging . 2001;22:575–580
  49. Ravaglia G , Forti P , Maioli F , et al.   Incidence and etiology of dementia in a large elderly Italian population . Neurology . 2005;64:1525–1530
  50. Yaffe K , Barnes D , Nevitt M , et al.   A prospective study of physical activity and cognitive decline in elderly women: women who walk . Arch Intern Med . 2001;161:1703–1708
  51. Barnes DE , Yaffe K , Satariano WA , et al.   A longitudinal study of cardiorespiratory fitness and cognitive function in healthy older adults . J Am Geriatr Soc . 2003;51:459–465
  52. Karp A , Paillard-Borg S , Wang HX , et al.   Mental, physical and social components in leisure activities equally contribute to decrease dementia risk . Dement Geriatr Cogn Disord . 2006;21:65–73
  53. Laurin D , Verreault R , Lindsay J , et al.   Physical activity and risk of cognitive impairment and dementia in elderly persons . Arch Neurol . 2001;58:498–504
  54. Abbott RD , White LR , Ross GW , et al.   Walking and dementia in physically capable elderly men . JAMA . 2004;292:1447–1453
  55. Heyn P , Abreu BC , Ottenbacher KJ . The effects of exercise training on elderly persons with cognitive impairment and dementia: a meta-analysis . Arch Phys Med Rehabil . 2004;85:1694–1704
  56. Lautenschlager NT , Cox KL , Flicker L , et al.   Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial . JAMA . 2008;300:1027–1037
  57. Reuben DB , Judd-Hamilton L , Harris TB , et al.   The associations between physical activity and inflammatory markers in high-functioning older persons: MacArthur Studies of Successful Aging . J Am Geriatr Soc . 2003;51:1125–1130
  58. Barnes DE , Whitmer RA , Yaffe K . Physical activity and dementia: the need for prevention trials . Exerc Sport Sci Rev . 2007;35:24–29
  59. Podewils LJ , Guallar E , Kuller LH , et al.   Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study . Am J Epidemiol . 2005;161:639–651
  60. Peters R , Poulter R , Warner J , et al.   Smoking, dementia and cognitive decline in the elderly, a systematic review . BMC Geriatr . 2008;8:36
  61. Aggarwal NT , Bienias JL , Bennett DA , et al.   The relation of cigarette smoking to incident Alzheimer's disease in a biracial urban community population . Neuroepidemiology . 2006;26:140–146
  62. Merchant C , Tang MX , Albert S , et al.   The influence of smoking on the risk of Alzheimer's disease . Neurology . 1999;52:1408–1412
  63. Juan D , Zhou DH , Li J , et al.   A 2-year follow-up study of cigarette smoking and risk of dementia . Eur J Neurol . 2004;11:277–282
  64. Lagnaoui R , Begaud B , Moore N , et al.   Benzodiazepine use and risk of dementia: a nested case–control study . J Clin Epidemiol . 2002;55:314–318
  65. Zandi PP , Sparks DL , Khachaturian AS , et al.   Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study . Arch Gen Psychiatry . 2005;62:217–224
  66. Wolozin B , Wang SW , Li NC , et al.   Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease . BMC Med . 2007;5:20
  67. Forette F , Seux ML , Staessen JA , et al.   Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial . Lancet . 1998;352:1347–1351
  68. Tzourio C , Anderson C , Chapman N , et al.   Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease . Arch Intern Med . 2003;163:1069–1075
  69. Lithell H , Hansson L , Skoog I , et al.   The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial . J Hypertens . 2003;21:875–886
  70. Applegate WB , Pressel S , Wittes J , et al.   Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program . Arch Intern Med . 1994;154:2154–2160
  71. Forette F , Seux ML , Staessen JA , et al.   The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study . Arch Intern Med . 2002;162:2042–2046
  72. Paganini-Hill A , Henderson VW . Estrogen deficiency and risk of Alzheimer's disease in women . Am J Epidemiol . 1994;140:256–261
  73. Tang MX , Jacobs D , Stern Y , et al.   Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease . Lancet . 1996;348:429–432
  74. Kawas C , Resnick S , Morrison A , et al.   A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging . Neurology . 1997;48:1517–1521
  75. Yaffe K , Sawaya G , Lieberburg I , et al.   Estrogen therapy in postmenopausal women: effects on cognitive function and dementia . JAMA . 1998;279:688–695
  76. Waring SC , Rocca WA , Petersen RC , et al.   Postmenopausal estrogen replacement therapy and risk of AD: a population-based study . Neurology . 1999;52:965–970
  77. Zandi PP , Carlson MC , Plassman BL , et al.   Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study . JAMA . 2002;288:2123–2129
  78. Shumaker SA , Legault C , Rapp SR , et al.   Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial . JAMA . 2003;289:2651–2662
  79. Barrett-Connor E , Kritz-Silverstein D . Estrogen replacement therapy and cognitive function in older women . JAMA . 1993;269:2637–2641
  80. Matthews K , Cauley J , Yaffe K , et al.   Estrogen replacement therapy and cognitive decline in older community women . J Am Geriatr Soc . 1999;47:518–523
  81. Eriksen JL , Sagi SA , Smith TE , et al.   NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo . J Clin Invest . 2003;112:440–449
  82. Weggen S , Eriksen JL , Das P , et al.   A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity . Nature . 2001;414:212–216
  83. Rich JB , Rasmusson DX , Folstein MF , et al.   Nonsteroidal anti-inflammatory drugs in Alzheimer's disease . Neurology . 1995;45:51–55
  84. Szekely CA , Thorne JE , Zandi PP , et al.   Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review . Neuroepidemiology . 2004;23:159–169
  85. Wyss-Coray T . Inflammation in Alzheimer disease: driving force, bystander or beneficial response? . Nat Med . 2006;12:1005–1015
  86. Aisen PS , Schafer KA , Grundman M , et al.   Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial . JAMA . 2003;289:2819–2826
  87. Thal LJ , Ferris SH , Kirby L , et al.   A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment . Neuropsychopharmacology . 2005;30:1204–1215
  88. Szekely CA , Breitner JC , Fitzpatrick AL , et al.   NSAID use and dementia risk in the Cardiovascular Health Study: role of APOE and NSAID type . Neurology . 2008;70:17–24
  89. Scharf JM , Daffner KR . NSAIDs in the prevention of dementia: a Cache-22? . Neurology . 2007;69:235–236
  90. ADAPT Research Group  . Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT) . PLoS Clin Trials . 2006;1:e33
  91. Yan Q , Zhang J , Liu H , et al.   Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease . J Neurosci . 2003;23:7504–7509
  92. Zilka N , Ferencik M , Hulin I . Neuroinflammation in Alzheimer's disease: protector or promoter? . Bratisl Lek Listy . 2006;107:374–383
  93. Cobb JL , Wolf PA , Au R , et al.   The effect of education on the incidence of dementia and Alzheimer's disease in the Framingham Study . Neurology . 1995;45:1707–1712
  94. Chibnall JT , Eastwood R . Postsecondary education and dementia risk in older Jesuit priests . Int Psychogeriatr . 1998;10:359–368
  95. Shadlen MF , Siscovick D , Fitzpatrick AL , et al.   Education, cognitive test scores, and black-white differences in dementia risk . J Am Geriatr Soc . 2006;54:898–905
  96. Wilson RS , Hebert LE , Scherr PA , et al.   Educational attainment and cognitive decline in old age . Neurology . 2009;72:460–465
  97. Karp A , Kareholt I , Qiu C , et al.   Relation of education and occupation-based socioeconomic status to incident Alzheimer's disease . Am J Epidemiol . 2004;159:175–183
  98. O'Keefe JH , Bybee KA , Lavie CJ . Alcohol and cardiovascular health: the razor-sharp double-edged sword . J Am Coll Cardiol . 2007;50:1009–1014
  99. Peters R , Peters J , Warner J , et al.   Alcohol, dementia and cognitive decline in the elderly: a systematic review . Age Ageing . 2008;37:505–512
  100. Mukamal KJ , Kuller LH , Fitzpatrick AL , et al.   Prospective study of alcohol consumption and risk of dementia in older adults . JAMA . 2003;289:1405–1413
  101. Xu G , Liu X , Yin Q , et al.   Alcohol consumption and transition of mild cognitive impairment to dementia . Psychiatry Clin Neurosci . 2009;63:43–49
  102. Luchsinger JA , Tang MX , Siddiqui M , et al.   Alcohol intake and risk of dementia . J Am Geriatr Soc . 2004;52:540–546
  103. Luchsinger JA , Mayeux R . Adiposity and Alzheimer's disease . Curr Alzheimer Res . 2007;4:127–134
  104. Beydoun MA , Beydoun HA , Wang Y . Obesity and central obesity as risk factors for incident dementia and its sub-types: a systematic review and meta-analysis . Obes Rev . 2008;9:204–218
  105. Fitzpatrick AL , Kuller LH , Lopez OL , et al.   Midlife and late-life obesity and the risk of dementia: cardiovascular health study . Arch Neurol . 2009;66:336–342
  106. Buchman AS , Wilson RS , Bienias JL , et al.   Change in body mass index and risk of incident Alzheimer disease . Neurology . 2005;65:892–897
  107. Forette F , Boller F . Hypertension and the risk of dementia in the elderly . Am J Med . 1991;90:14S–19S
  108. Posner HB , Tang MX , Luchsinger J , et al.   The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function . Neurology . 2002;58:1175–1181
  109. Craft S . Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment . Curr Alzheimer Res . 2007;4:147–152
  110. Sun MK , Alkon DL . Links between Alzheimer's disease and diabetes . Drugs Today (Barc) . 2006;42:481–489
  111. Starkstein SE , Almeida OP . Understanding cognitive impairment and dementia: stroke study . Curr Opin Psychiatry . 2003;16:615–620
  112. Dunn N , Mullee M , Perry VH , et al.   Association between dementia and infectious disease: evidence from a case– control study . Alzheimer Dis Assoc Disord . 2005;19:91–94
  113. Corder EH , Robertson K , Lannfelt L , et al.   HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy . Nat Med . 1998;4:1182–1184
  114. Forton DM , Thomas HC , Murphy CA , et al.   Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease . Hepatology . 2002;35:433–439
  115. Lye TC , Shores EA . Traumatic brain injury as a risk factor for Alzheimer's disease: a review . Neuropsychol Rev . 2000;10:115–129
  116. Fleminger S , Oliver DL , Lovestone S , et al.   Head injury as a risk factor for Alzheimer's disease: the evidence 10 years on; a partial replication . J Neurol Neurosurg Psychiatry . 2003;74:857–862
  117. Ownby RL , Crocco E , Acevedo A , et al.   Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis . Arch Gen Psychiatry . 2006;63:530–538
  118. Jorm AF . History of depression as a risk factor for dementia: an updated review . Aust N Z J Psychiatry . 2001;35:776–781
  119. Solfrizzi V , Colacicco AM , D'Introno A , et al.   Macro-nutrients, aluminium from drinking water and foods, and other metals in cognitive decline and dementia . J Alzheimers Dis . 2006;10:303–330
  120. Rondeau V , Commenges D , Jacqmin-Gadda H , et al.   Relation between aluminum concentrations in drinking water and Alzheimer's disease: an 8-year follow-up study . Am J Epidemiol . 2000;152:59–66
  121. Yonekawa M , Okabe T , Asamoto Y , et al.   A case of hereditary ceruloplasmin deficiency with iron deposition in the brain associated with chorea, dementia, diabetes mellitus and retinal pigmentation: administration of fresh-frozen human plasma . Eur Neurol . 1999;42:157–162
  122. Danscher G , Jensen KB , Frederickson CJ , et al.   Increased amount of zinc in the hippocampus and amygdala of Alzheimer's diseased brains: a proton-induced X-ray emission spectroscopic analysis of cryostat sections from autopsy material . J Neurosci Methods . 1997;76:53–59
  123. Shore D , Henkin RI , Nelson NR , et al.   Hair and serum copper, zinc, calcium, and magnesium concentrations in Alzheimer-type dementia . J Am Geriatr Soc . 1984;32:892–895
  124. Kipen E , Helme RD , Wark JD , et al.   Bone density, vitamin D nutrition, and parathyroid hormone levels in women with dementia . J Am Geriatr Soc . 1995;43:1088–1091
  125. Petersen RC , Thomas RG , Grundman M , et al.   Vitamin E and donepezil for the treatment of mild cognitive impairment . N Engl J Med . 2005;352:2379–2388
  126. Otsuka M , Yamaguchi K , Ueki A . Similarities and differences between Alzheimer's disease and vascular dementia from the viewpoint of nutrition . Ann NY Acad Sci . 2002;977:155–161

PII: S0929-6646(09)60402-2

doi: 10.1016/S0929-6646(09)60402-2

Journal of the Formosan Medical Association
Volume 108, Issue 10 , Pages 754-764 , October 2009

Article Tools